BioSpace News Archive

Company Completes Critical Milestone in Development of “Universal Donor” Stem Cell Therapy for Stroke

Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced the publication of an independent, systematic review and meta-analysis demonstrating that its DecisionDx®-Melanoma test is a significant predictor of recurrence and metastatic risk in patients with invasive cutaneous melanoma.

ChemoCentryx, Inc., (NASDAQ: CCXI) today confirmed that the Company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for avacopan for the treatment of patients with ANCA-associated vasculitis. The Company’s NDA submission is supported by the results of its pivotal Phase III ADVOCATE trial, which demonstrated statistical superiority in sustaining remission at 52 weeks in the avacopan group compar

Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced preliminary financial results for the quarter ended June 30, 2020, and provided business updates. Preliminary Second Quarter Financial Results Preliminary total net product revenues for the second quarter are expected to be approximately $20 million, including approximately $15 million of MACI ® (autol

CereHealth Corp., a recognized leader and innovator in biotechnology applications and advanced neurodiagnostics, announced today that its FDA-cleared population template, an alternative to traditional normative datasets for quantitative analysis of clinical brain SPECT, will be presented by the company’s Senior Medical Imaging Engineer, Lindsay Quandt, MS, MBA, at SNMMI’s Annual Meeting on July 11-14

COVID-19 patients have begun enrolling in an interventional clinical trial at Hospital Virgen del Carmen in Zarate, Argentina.

EGF THERAMED HEALTH CORP. (CSE:TMED)(OTC PINK:EVAHF)(FRANKFURT:AUHP) (the “Company”) announces that Global Green Parrot Laboratories Inc. (“GGP”) has entered into a Memorandum of Understanding (“MOU”) with Greenfield Global Projects Inc. (“Greenfield”)

Innovega Inc. announced the appointment of Casey Tegreene as a Strategic and Technical Advisor to the company. Casey has decades of experience inventing, developing, protecting and commercializing a wide range of advanced technologies.

HMS Holdings Corp. (Nasdaq: HMSY) today announced it will report financial and operating results for the second quarter and six month periods ending June 30, 2020 on Friday, August 7, 2020 before market open.

Therapix Biosciences Ltd. (OTC Pink: TRPXY) (the “Company”), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced today that its American Depositary Shares (“ADSs”) will now trade under the OTC Pink ticker symbol “TRPXY.” The Company also announced the removal by an